Maze Therapeutics reported total assets of $531.62M and total liabilities of $78.50M for the quarter ended Jun 2026, up 75.2% year over year. This balance sheet covers 10 quarters of results from Mar 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 16.87M | 19.21M | ||||||||
| Receivables - AccuredAcc. Int. Receivables | 0.70M | 1.50M | 1.80M | 2.80M | ||||||
| Assets | ||||||||||
| Current Assets | ||||||||||
| Cash & EquivalentsCash & Equiv. | 30.02M | 175.06M | 149.61M | 196.81M | 294.37M | 264.54M | 316.77M | 189.25M | 198.77M | 202.64M |
| Receivables - NetNet Receivables | 20.00M | |||||||||
| Receivables | 20.00M | |||||||||
| Prepaid Assets | 4.86M | 5.33M | 6.61M | 7.37M | 7.80M | 7.40M | 9.34M | |||
| Current Assets | 201.67M | 299.71M | 271.15M | 391.30M | 349.72M | 379.78M | 420.42M | |||
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment (Net) | 6.67M | 6.31M | 6.01M | 5.54M | 5.04M | 4.68M | 4.39M | |||
| Long-Term Investments | 18.11M | 10.56M | 83.82M | |||||||
| Other Non-Current Assets | 7.87M | 1.09M | 1.09M | 3.21M | 3.05M | 4.32M | 3.46M | |||
| Non-Current Assets | 38.87M | 33.13M | 32.37M | 30.76M | 47.41M | 39.93M | 111.20M | |||
| Assets | 240.54M | 332.84M | 303.52M | 422.06M | 397.13M | 419.71M | 531.62M | |||
| Liabilities | ||||||||||
| Current Liabilities | ||||||||||
| Accounts Payables | 1.94M | 2.40M | 3.67M | 2.92M | 1.79M | 4.01M | 2.21M | |||
| Payables | 1.94M | 2.40M | 3.67M | 2.92M | 1.79M | 4.01M | 2.21M | |||
| Accumulated Expenses | 14.10M | 11.54M | 11.52M | 14.43M | 15.97M | 12.38M | 15.87M | |||
| Other Accumulated Expenses | 2.93M | 4.95M | 5.07M | 4.30M | 5.04M | 7.01M | ||||
| Total Current Liabilities | 20.67M | 18.62M | 19.90M | 22.11M | 22.56M | 21.24M | 22.96M | |||
| Non-Current Liabilities | ||||||||||
| Non-Current Debt | 38.83M | 38.96M | ||||||||
| Preferred Stock Liabilities | 383.90M | 383.90M | 383.90M | 508.09M | ||||||
| Operating Leases | 22.00M | 21.15M | 20.29M | 19.42M | 18.51M | 17.55M | 16.58M | |||
| Other Non-Current Liabilities | 0.97M | 1.01M | 1.09M | 1.09M | 1.09M | 0.39M | ||||
| Total Non-Current Liabilities | 550.76M | 39.77M | 40.19M | 41.53M | 41.07M | 77.62M | ||||
| Total Liabilities | 551.73M | 40.77M | 41.28M | 42.62M | 42.16M | 78.01M | 78.50M | |||
| Shareholder's Equity | ||||||||||
| Total Debt | 38.83M | 38.96M | ||||||||
| Common Equity | -403.66M | -262.37M | -284.53M | -311.18M | 292.07M | 262.24M | 379.44M | 354.97M | 341.70M | 453.12M |
| Liabilities and Shareholders Equity | 240.54M | 332.84M | 303.52M | 422.06M | 397.13M | 419.71M | 531.62M | |||
| Retained Earnings | -358.43M | -391.21M | -424.90M | -455.00M | -489.55M | -513.80M | -558.50M |
Pull Maze Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=MAZE&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "MAZE", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=MAZE&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();